Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marstacimab for Hemophilia A or B With or Without Inhibitors
CTR20211956Phase 3Completed
- Sponsor
- ---
- Start
- Aug 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of marstacimab in hemophilia A, hemophilia B (HB), sponsored by ---. Started Aug 2021; status: completed.
02
Drugs
marstacimab
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on CTR20211956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211956.